Although typically classified as a single ethnic group, people of Hispanic heritage have markedly different risks for brain tumors based on their geographic origins, suggesting greater diversity that warrants attention in ...
Aug 4, 2022
0
16
Researchers at Massachusetts General Hospital (MGH) who previously developed a blood test for mutations in a gene linked to gliomas, the most common type of adult brain tumors, have now applied their technology to detect ...
Jul 22, 2022
0
56
Researchers have discovered that infiltrating gliomas, a common brain and spinal cord tumor, are shaped by their genetic evolution and microenvironment, a finding that could lead to more targeted treatments.
Jun 9, 2022
0
40
How tumors emerge has always been quite a conundrum in the scientific community.
May 25, 2022
0
77
Glioma is the most frequently identified intracranial tumor in adults. Mapping the cerebrovascular network remodeling at the macroscopic level may provide an alternative approach to assessing hemodynamic dysregulation in ...
Apr 20, 2022
0
3
Researchers from the HSE Centre for Language and Brain worked with Russian doctors to address the differences between the symptoms of post-stroke aphasia and aphasia caused by glioma surgery. Post-surgery patients demonstrate ...
Apr 1, 2022
0
3
Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response. But findings from a team at the University of Michigan Rogel Cancer Center, led by Carl Koschmann, M.D., pediatric neuro-oncologist ...
Mar 24, 2022
0
30
A mutated gene affects growth of brain tumor cells in young adults, indicating sensitivity to a new treatment strategy, a team of researchers at the University of Michigan Rogel Cancer Center discovered. These findings, recently ...
Jan 19, 2022
0
34
Researchers from four academic neurosurgical centers in Japan found that the parietooccipital fissure, which divides the temporal, occipital, and parietal lobes of the brain, acts as an obstacle that may result in less invasion ...
Dec 14, 2021
0
6
A combination of two targeted cancer drugs showed unprecedented, "clinically meaningful" activity in patients with highly malignant brain tumors that carried a rare genetic mutation, according to a clinical trial report by ...
Nov 25, 2021
0
151
